Antiallergic effects of peiminine through the regulation of inflammatory mediators in HMC-1 cells. (August 2015)

• Record Type: Journal Article
• Authors: Lee, Bina; Kim, Eun-Young; Kim, Jae-Hyun; Min, Ju-Hee; Jeong, Da-Won; Jun, Jae-Yun; Cho, Chang-Young; Sohn, Youngjoo; Jung, Hyuk-Sang
• Is Part Of: Immunopharmacology and immunotoxicology. Volume 37:Number 4(2015:Aug.)
• Page Start: 351
• Page End: 358
• Publication Date: 2015-08
• Subjects: Immunopharmacology -- Periodicals; Immunotoxicology -- Periodicals; Antibody-toxin conjugates -- Periodicals; Immunology -- Periodicals; 615.37
• Languages: English
• ISSNs: 0892-3973

Abstract

<abstract> <title>Abstract</title> <p>Peiminine is the main biologically active component derived from <italic>Fritillaria ussuriensis</italic>. Peiminine was investigated in various pulmonary diseases, but its antiallergic effect and the related mechanism have not been reported yet. The present study aimed to evaluate the effect of peiminine on mast cell-mediated allergic inflammation in HMC-1 cells. The pro-inflammatory cytokine production was measured using ELISA, reverse transcription-polymerase chain reaction and nuclear factor-kappaB (NF-κB), mitogen-activated protein kinases (MAPKs) pathway activation, as determined by Western blot analysis. Peiminine inhibits the production of the pro-inflammatory cytokine, such as interleukin (IL)-6, IL-8, tumor necrosis factor-alpha (TNF-α) and IL-1beta (IL-1β). It was shown to have inhibitory effects on MAPKs phosphorylation and NF-B expression in human mast cells (HMC)-1 using Western blot. HMC-1 cells were observed for confirmation of histamine release. Passive cutaneous anaphylaxis (PCA) reactions were evaluated using an animal model and peiminine demonstrated inhibitory effects on IgE-dependent anaphylaxis. These results suggest that peiminine has regulatory potential for allergic inflammatory reactions mediated by HMC-1 cells.</p> </abstract>